Skip to main content
. 2016 Sep 16;7(45):73792–73799. doi: 10.18632/oncotarget.12071

Table 1. Summary of the PTV coverage for DCA, IMRT and RA techniques.

DCA IMRT RA P Value
Mean(Range) Mean(Range) Mean(Range) DCA vs IMRT DCA vs RA IMRT vs RA
D2%(cGy) 5505.86(5338.93-5703.29) 5549.79 (5243.5-5873.48) 5202.44 (4999.8-5424.88) 0.554 0.000 0.472
D98%(cGy) 4702.74(4667.81-4730.1) 4681.74 (4584.37-4725.8) 4726.25 (4691.8-4755.8) 0.190 0.017 0.793
D50%(cGy) 5177.64(5129.5-5279.85) 5259.60 (5103.1-5587.32) 5081.66 (4916.4-5247.98) 0.117 0.010 0.338
V90%(%) 99.99(99.93-100) 99.91(99.37-100) 100(99.96-100) 0.225 0.714 0.511
V95%(%) 99.68(99.27-100) 99.44(98.2-99.9) 99.87(99.54-100) 0.261 0.072 0.910
V100%(%)* 95 95 95 - - -
V105%(%) 72.95(68.2-80.33) 77.05(63.4-86.79) 54.63(0-80.57) 0.159 0.046 0.744
*

Due to all plans were normalized to 100% of prescribed dose covering 95% of the PTV, the value of the V100%(%) for each plan was 95.